In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Study: Ongoing replication stress tolerance and clonal T cell responses distinguish ... profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A recent study revealed that bevacizumab (Avastin) provides survival benefits in patients with colorectal cancer (CRC) for ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

For instance, a study on colorectal cancer liver metastasis utilized single-cell ... into tissue-specific gene expression and the clonal distribution of immune cells across different tissues ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

Clonal hematopoiesis (CH) has been associated with a variety of adverse outcomes, most notably hematologic malignancy and ischemic cardiovascular disease. A series of recent studies also suggest that ...

Safety, tolerability, and preliminary efficacy of tinodasertib as a monotherapy or in combination with pembrolizumab or irinotecan in metastatic colorectal cancer: Interim results from a phase II open ...